Patents

Pursuant to 35 U.S.C. §287(a), Cardiologs Technologies products are protected by one or more U.S. patents. Each product also may be covered by one or more foreign patents and additional patent application(s) may still be pending.

The following list of products and U.S. patents may not be all inclusive, and other products not listed here may be protected by one or more patents.

Product Patents
Cardiologs ECG Analysis Platform US10426364, US10758139, US10779744, US10959660
Cardiologs ECG Analysis Platform EP Patent No. 3367897 (AT, BE, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LT, LU, LV, NL, NO, PL, PT, RO, SE, TR)

PRESS RELEASES & NEWS

Swipe Left Below

New Study Published in JACC Clinical EP Validates that Cardiologs’ AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for AFib

PARIS and BOSTON, Feb. 10, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that results of a clinical study the company conducted in collaboration with Valley Health System…

READ FULL
PRESS RELEASE to article

Rick Anderson and Mark Toland Join Cardiologs’ Board of Directors

PARIS and BOSTON, Oct. 7, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) for cardiac diagnostics, announced today that it has appointed two veteran medical device industry executives to the company’s board…

READ FULL
PRESS RELEASE to article

Cardiologs Partners with MicroPort CRM to Distribute its AI-based Cardiac Diagnostics Solution in France

The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders. BOSTON, Sept. 1, 2020 /PRNewswire/ — Cardiologs, a global…

READ FULL
PRESS RELEASE to article

Clinical Study Shows Cardiologs’ AI Reduces The False Positive Burden Of Implantable Loop Recorders By Almost 70%

Data presented at HRS 2020 shows Cardiologs’ AI-system successfully eliminates more than two-thirds of atrial fibrillation false positives from ILR reports, alleviating the clinical burden associated with remote monitoring PARIS…

READ FULL
PRESS RELEASE to article

Cardiologs Announces Clinical Study to Monitor Cardiac Safety of COVID-19 Patients Via Smartwatches

Trial will evaluate use of Cardiologs’ AI platform for QT interval analysis of ECG data from smartwatches in patients receiving hydroxychloroquine treatment BOSTON, April 22, 2020 /PRNewswire/ — Cardiologs, a…

READ FULL
PRESS RELEASE to article

Cardiologs Raises $15 Million in Series A Funding Led by Alven

Funding will accelerate adoption of the company’s breakthrough AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities PARIS and BOSTON, Jan. 10, 2020 /PRNewswire/ — Cardiologs, a global leader…

READ FULL
PRESS RELEASE to article